Skip to main content
. 2023 Mar 5;14(4):657–664. doi: 10.7150/jca.81616

Table 1.

Demographic information of lung cancer patients with and without PTB.

Variables Lung cancer patients P-value
Without PTB
N (%) = 70,458 (98.14)
With PTB
N (%) = 1,335 (1.86)
Sex
Male 42,219 (97.7) 994 (2.3) <0.01
Female 28,239 (98.8) 341 (1.2)
Age(years)
<50 6,531 (98.7) 85 (1.3) <0.01
50-59 13,494 (98.5) 200 (1.5)
60-69 17,460 (98.2) 316 (1.9)
≥70 32,973 (97.8) 734 (2.2)
Clinical stage
I 11,918 (98.0) 240 (2.0) <0.01
II 2,837 (97.3) 79 (2.7)
III 13,343 (97.4) 354 (2.6)
IV 42,360 (98.5) 662 (1.5)
Small cell 5,714 (98.0) 115 (2.0) 0.50
Operation, yes 16,230 (97.7) 377 (2.3) <0.01
Chemotherapy, yes 37,599 (98.0) 783 (2.0) <0.01
Radiation therapy, yes 20,094 (98.1) 386 (1.9) 0.75
Comorbidity
Diabetes 13,529 (98.3) 238 (1.7) 0.21
COPD 11,818 (97.7) 274 (2.3) <0.01
Renal disease 2,605 (98.4) 43 (1.6) 0.36
Pneumoconiosis 196 (93.3) 14 (6.7) <0.01
Hypertension 11,602 (98.4) 191 (1.6) 0.04
Dyslipidemia 1,380 (98.8) 17 (1.2) 0.07
Ischemic Heart Disease 2,706 (98.5) 42 (1.5) 0.19
Cerebrovascular Disease 1,439 (98.5) 22 (1.5) 0.31
Smoking, missing N=30,516
No 21,870 (98.8) 261 (1.2) <0.01
Yes 18,760 (98.0) 386 (2.0)